Annals of Surgical Oncology

, Volume 8, Issue 4, pp 338–341 | Cite as

Clinical Presentation and Treatment of Non-Hodgkin’s Lymphoma of the Thyroid Gland

  • Debrah A. Wirtzfeld
  • Janet S. Winston
  • Wesley L. HicksJr.
  • Thom R. Loree
Original Articles

Abstract

Background: Non-Hodgkin’s lymphoma (NHL) of the thyroid is a rare malignancy. The traditional approach to curative treatment of localized (stages I and II) NHL of the thyroid gland is surgical resection. The recent success of multimodality chemoradiotherapy suggests that surgery should be reserved for providing a tissue diagnosis or relief from acute airway obstruction. It is questionable whether this has made an impact on treatment approaches.

Methods: Retrospective chart review was conducted for all cases of localized NHL of the thyroid gland treated at Roswell Park Cancer Institute between January 1970 and January 1999.

Results: Ten patients (8 women, 2 men) with a mean age of 56.8 years were identified. Nine patients (90%) presented with a neck mass; seven patients (70%) had a history of Hashimoto’s disease. Nine patients (90%) had extensive investigations to rule out extrathyroidal disease. All patients were treated with either a total thyroidectomy (eight patients) or a thyroid lobectomy (two patients). Nine (90%) were initially treated outside of Roswell Park Cancer Institute and referred secondarily for consideration of further therapy. Adjuvant therapy consisting of cyclophosphamide-based chemoradiotherapy was administered to nine patients. Overall survival was 80% at a mean follow-up of 8.6 years with a disease-specific survival rate of 100%.

Conclusions: A review of the literature suggests that fine needle aspiration (FNA) with flow cytometry and immunohistochemistry can be used to accurately diagnose NHL of the thyroid gland. Open biopsy should be reserved for cases where this technique is not available or where the diagnosis can not be confirmed by FNA alone. Extrathyroidal NHL should be ruled out by chest x-ray, CT scan of the abdomen, and bone marrow biopsy. Further review suggests that the most efficacious therapy is systemic chemotherapy in combination with radiation for local control. Debulking surgery should be used only to provide relief from acute airway obstruction.

Key Words:

Thyroid lymphoma Staging Treatment 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aozasa K, Inoue A, Tajima A, Miyauchi A, Matsuzuka F, Kuma K. Malignant lymphoma of the thyroid gland: Analysis of 79 patients with an emphasis on histologic prognostic factors. Cancer 1986; 58: 100–104.PubMedGoogle Scholar
  2. 2.
    Staunton H, Greening W. Clinical diagnosis of thyroid cancer. BMJ 1973; 4: 532–535.CrossRefPubMedGoogle Scholar
  3. 3.
    Banfi A, Bonadonna G, Carnevali G, Oldini C, Salvini E. Preferential sites of involvement and spread in malignant lymphoma. Eur J Cancer 1968; 4: 319–324.PubMedGoogle Scholar
  4. 4.
    Freeman C, Berg J, Cutler S. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29: 252–260.PubMedGoogle Scholar
  5. 5.
    Naylor B. Secondary lymphoblastomatous involvement of the thyroid gland. Arch Pathol 1959; 67: 432–438.Google Scholar
  6. 6.
    Rasbach D, Mondschein M, Harris N. Malignant lymphoma of the thyroid gland: A clinical and pathologic study of twenty cases. Surgery 1985; 98: 1166–1170.PubMedGoogle Scholar
  7. 7.
    Scholefield J, Quayle A, Harris S, Talbot C. Primary lymphoma of the thyroid, the association with Hashimoto’s thyroiditis. Eur J Surg Oncol 1992; 18: 89–92.PubMedGoogle Scholar
  8. 8.
    Isaacson P, Wright D. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 1984; 53: 2515–2524.PubMedGoogle Scholar
  9. 9.
    Anscombe A, Wright D. Primary malignant lymphoma of the thyroid–a tumour of mucosa-associated lymphoid tissue: A review of seventy-six cases. Histopathology 1985; 9: 81–97.PubMedCrossRefGoogle Scholar
  10. 10.
    Isaacson P, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 1987; 11: 445–462.PubMedGoogle Scholar
  11. 11.
    Butler J, Brady L, Amendola B. Lymphoma of the thyroid: Report of five cases and review. Am J Clin Oncol 1990; 13: 64–69.PubMedGoogle Scholar
  12. 12.
    Pasieka J. Anaplastic cancer, lymphoma and metastases of the thyroid gland. Surg Oncol Clin North Am 1998; 4: 707–720.Google Scholar
  13. 13.
    Joensuu H, Klemi PJ, Eerola E. Diagnostic nature of DNA flow cytometry combined with fine needle aspiration biopsy in lymphomas. J Pathol 1988; 154: 237–245.PubMedGoogle Scholar
  14. 14.
    Detweiler RE, Katz RL, Alapat C, El-Naggar A, Ordonez N. Malignant lymphoma of the thyroid: A report of two cases diagnosed by fine-needle aspiration. Diagn Cytopath 1991; 7: 163–171.Google Scholar
  15. 15.
    Lovchik J, Lane MA, Clark DP. Polymerase chain reaction-based detection of B-cell clonality in the fine needle aspiration biopsy of a thyroid mucosa-associated lymphoid tissue (MALT) lymphoma. Hum Pathol 1997; 28: 989–992.PubMedGoogle Scholar
  16. 16.
    Evans T, Mansi J, Bevan D, Dalgleish A, Harmer C. Primary non-hodgkin’s lymphoma of the thyroid with bone marrow infiltration at presentation. Clin Oncol 1995; 7: 54–55.Google Scholar
  17. 17.
    Doria R, Jekel J, Cooper D. Thyroid lymphoma: The case for combined modality therapy. Cancer 1994; 73: 200–206.PubMedGoogle Scholar
  18. 18.
    Holme L, Braugren H, Lowhagen T. Cancer risk in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312: 601–604.PubMedCrossRefGoogle Scholar
  19. 19.
    Hyjek E, Isaacson P. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto’s thyroiditis. Human Pathol 1988; 19: 1315–1326.Google Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2001

Authors and Affiliations

  • Debrah A. Wirtzfeld
    • 1
  • Janet S. Winston
    • 2
  • Wesley L. HicksJr.
    • 1
  • Thom R. Loree
    • 1
    • 3
  1. 1.Divisions of Surgical Oncology (DAW, WLH, TRL)Roswell Park Cancer InstituteBuffalo
  2. 2.Divisions of Surgical Pathology (JSW)Roswell Park Cancer InstituteBuffalo
  3. 3.Division of Surgical OncologyRoswell Park Cancer InstituteBuffalo

Personalised recommendations